June 11, 2025 - 15:00 BST / 16:00 CEST / 10:00 EDT / 07:00 PDT

Join our expert, Sally Benton, Consultant Biochemist and Clinical Lead for Clinical and Specialist Biochemistry Services at Berkshire and Surrey Pathology Services and Royal Surrey County Hospital NHS Foundation Trust, for an educational session on the critical role laboratories play in the early detection of colorectal cancer (CRC) and how advancements in testing methods and programs can significantly improve patient outcomes. In this session, we will emphasize the importance of early detection in enhancing patient prognosis while addressing the unique challenges laboratories face in supporting global colorectal cancer screening initiatives. You will gain a clinical overview of colorectal cancer and learn how laboratories are essential in meeting the growing demand for early detection worldwide. Expert insights will be shared on strategies and best practices for implementing or optimizing colorectal cancer testing programs in your laboratory, as well as how to effectively triage patients to the appropriate clinical pathways for better care and outcomes. The webinar will also cover various laboratory testing methodologies, with a particular focus on the fecal immunochemical test (FIT) — a widely recommended screening method used in many global programs. We will explore key considerations across the preanalytical, analytical, and post-analytical phases, including best practices for sample collection, processing, and expert guidance on establishing thresholds and reporting results. Additionally, we will discuss the importance of maintaining quality assurance through external quality assessment programs and stringent quality control measures to ensure consistent and reliable results. The session will also highlight the latest trends and developments in colorectal cancer detection and fecal immunochemical testing. You will gain valuable expert insights and practical strategies to enhance your colorectal cancer testing practices and ultimately improve patient care.

Key learning objectives
 
Develop actionable strategies and best practices for implementing or optimizing colorectal cancer testing programs.
 
Implement protocols, patient education, and programs to minimize variability in the preanalytical phase, ensuring consistency in patient collection, processing, and results.
 
Create strategies and protocols to address analytical challenges and establish quality monitoring systems to ensure reliable results.

Who should attend?

Healthcare professionals, clinical staff, lab technicians, pathologists, lab directors, and outpatient services facilities.

Accreditation statement

SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of these webinars may be entitled to 1.0 ACCENT Continuing Education Credits from the ADLM. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@myadlm.org
 

Presenters

Sally C Benton, BSc, MSc, FRCPath
Sally C Benton, BSc, MSc, FRCPath

Consultant Biochemist and Clinical Lead for Clinical and Specialist Biochemistry Services,

Berkshire and Surrey Pathology Services and Royal Surrey County Hospital NHS Foundation Trust, Guildford, England

Sally Benton is a globally recognized thought leader in colorectal cancer (CRC) with years of expertise in fecal testing, early diagnosis, research, and future development. As clinical lead and consultant clinical scientist at Berkshire and Surrey Pathology Services, Royal Surrey County Hospital, Guildford, England, she leads both clinical biochemistry services and innovative research in fecal testing and early diagnosis of CRC. She serves as director of the NHS Bowel Cancer Screening Hub for the South of England, where she oversees the CRC screening laboratory and works with NHS England screening centres to ensure a safe and high-quality FIT screening program across the southern region. She is the chair of the IFCC Working Group for FIT and co-chairs the World Endoscopy Organization FIT for Screening Committee.

Dora Wells
Dora Wells

Editorial Team

SelectScience

Dora studied biomedical science at the University of Manchester, UK, and as a member of the editorial team, plays an integral role in helping to shape the content on SelectScience.

Register

Note: By completing this form, you will receive a free membership to SelectScience® and The Scientists’ Channel®. SelectScience is a trade organisation, we do not provide services to consumers and membership is for business purposes only. As a member you must provide us with a corporate email address to enable us (and our advertisers and sponsors) to contact you for marketing purposes. You can opt-out of marketing at any time. See our Privacy Policy

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

* Required Fields